Treatment of Infections Associated with Surgical Implants

New England Journal of Medicine

Volumn 350, Issue 14, 2004, Pages 1422-1429

  Darouiche, Rabih O ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; WARFARIN;

ANTIBIOTIC THERAPY; BACTERIAL GROWTH; BIOFILM; BLOOD VESSEL GRAFT; BREAST ENDOPROSTHESIS; CLINICAL FEATURE; CLINICAL PROTOCOL; CLINICAL TRIAL; DEFIBRILLATOR; DEVICE; ENDOCARDITIS; FRACTURE FIXATION; HEART ASSIST DEVICE; HEART VALVE PROSTHESIS; HOSPITAL INFECTION; HUMAN; IMPLANT; JOINT PROSTHESIS; MALE GENITAL SYSTEM SURGERY; PACEMAKER; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTHESIS INFECTION; PROSTHETIC VALVE ENDOCARDITIS; REVIEW; SALVAGE THERAPY;

ALGORITHMS; ANTI-BACTERIAL AGENTS; BIOFILMS; BLOOD VESSEL PROSTHESIS; BREAST IMPLANTS; CEREBROSPINAL FLUID SHUNTS; COMBINED MODALITY THERAPY; FEMALE; FRACTURE FIXATION, INTERNAL; HEART VALVE PROSTHESIS; HUMANS; JOINT PROSTHESIS; MALE; PACEMAKER, ARTIFICIAL; PENILE PROSTHESIS; PROSTHESIS-RELATED INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 1842483412     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMra035415     Document Type: Review

References (49)

1. Whitehouse JD, Friedman ND, Kirkland KB, Richardson WJ, Sexton DJ. The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol 2002;23:183-9.
2. Darouiche RO. Device-associated infections: a macroproblem that starts with microadherence. Clin Infect Dis 2001;33: 1567-72.
3. John MDV, Hibberd PL, Karchmer AW, Sleeper LA, Calderwood SB. Staphylococcus aureus prosthetic valve endocarditis: optimal management and risk factors for death. Clin Infect Dis 1998;26:1302-9.
4. Vongpatanasin W, Hillis LD, Lange RA. Prosthetic heart valves. N Engl J Med 1996; 335:407-16.
5. Kudva A, Hye RJ. Management of infectious and cutaneous complications in vascular access. Semin Vasc Surg 1997;10:184-90.
6. Gassel HJ, Klein I, Steger U, et al. Surgical management of prosthetic vascular graft infection: comparative retrospective analysis of 30 consecutive cases. VASA 2002;31: 48-55.
7. Coselli JS, Koksoy C, LeMaire SA. Management of thoracic aortic graft infections. Ann Thorac Surg 1999;67:1990-3.
8. Klug D, Lacroix D, Savoye C, et al. Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management. Circulation 1997;95:2098-107.
9. Ferguson TB Jr, Ferguson CL, Crites K, Crimmins-Reda P. The additional hospital costs generated in the management of complications of pacemaker and defibrillator implantations. J Thorac Cardiovasc Surg 1996;111:742-52.
10. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001;345:1435-43.
11. McCarthy PM, Schmitt SK, Vargo RL, Gordon S, Keys TF, Hobbs RE. Implantible LVAD infections: implications for permanent use of the device. Ann Thorac Surg 1996;61:359-65.
12. Stein A, Bataille JF, Drancourt M, et al. Ambulatory treatment of multidrug-resistant Staphylococcus-infected orthopedic implants with high-dose oral co-trimoxazole (trimethoprim-sulfamethoxazole). Antimicrob Agents Chemother 1998;42:3086-91.
13. Tattevin P, Cremieux A-C, Pottier P, Huten D, Carbon C. Prosthetic joint infection: when can prosthesis salvage be considered? Clin Infect Dis 1999;29:292-5.
14. Widmer AE. New developments in diagnosis and treatment of infection in orthopedic implants. Clin Infect Dis 2001;33:Suppl 2:S94-S106.
15. Boxma H, Broekhuizen T, Patka P, Oosting H. Randomised controlled trial of single-dose antibiotic prophylaxis in surgical treatment of closed fractures: the Dutch Trauma Trial. Lancet 1996;347:1133-7.
16. Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. JAMA 1998;279:1537-41.
17. Cochrane DD, Kestle J. Ventricular shunting for hydrocephalus in children: patients, procedures, surgeons and institutions in English Canada, 1989-2001. Eur J Pediatr Surg 2002;12:Suppl 1:S6-S11.
18. Naradzay JF, Browne BJ, Rolnick MA, Doherty RJ. Cerebral ventricular shunts. J Emerg Med 1999;17:311-22.
19. Gabriel SE, Woods JE, O'Fallon WM, Beard CM, Kurland LT, Melton LJ III. Complications leading to surgery after breast implantation. N Engl J Med 1997;336:677-82.
20. Wilson SK, Delk JR. II. Inflatable penile implant infection: predisposing factors and treatment suggestions. J Urol 1995;153: 659-61.
21. Darouiche RO. Antimicrobial approaches for preventing infections associated with surgical implants. Clin Infect Dis 2003;36: 1284-9.
22. Sierra J, Kalangos A, Faidutti B, Christenson JT. Aorto-enteric fistula is a serious complication to aortic surgery: modern trends in diagnosis and therapy. Cardiovasc Surg 2003;11:185-8.
23. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999;284:1318-22.
24. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002;15: 167-93.
25. Akowuah EF, Davies W, Oliver S, et al. Prosthetic valve endocarditis: early and late outcome following medical or surgical treatment. Heart 2003;89:269-72.
26. Lerakis S, Robert Taylor W, Lynch M, et al. The role of transesophageal echocardiography in the diagnosis and management of patients with aortic perivalvular abscesses. Am J Med Sci 2001;321:152-5.
27. Sasaki Y, Isobe F, Kinugasa S, et al. Early and late outcomes after reoperation for prosthetic valve endocarditis. Jpn J Thorac Cardiovasc Surg 2001;49:224-9.
28. Ako J, Ikari Y, Hatori M, Hara K, Ouchi Y. Changing spectrum of infective endocarditis. Circ J 2003;67:3-7.
29. Wallace SM, Walton BI, Kharbanda RK, Hardy R, Wilson AP, Swanton RH. Mortality from infective endocarditis: clinical predictors of outcome. Heart 2002;88:53-60.
30. Reilly L. Aortic graft infection: evolution in management. Cardiovasc Surg 2002;10: 372-7.
31. Darling KC III, Resnikoff M, Kreienberg PB, et al. Alternative approach for management of infected aortic grafts. J Vasc Surg 1997;25:106-12.
32. Lentino JR, Baddour LM, Wray M, Wong ES, Yu VL. Staphylococcus aureus and other bacteremias in hemodialysis patients: antibiotic therapy and surgical removal of access site. Infection 2000;28:355-60.
33. Lin PH, Brinkman WT, Terramani TT, Lumsden AB. Management of infected hemodialysis access grafts using cryopreserved human vein allografts. Am J Surg 2002;184:31-6.
34. Chiesa P, Astore D, Piccolo G, et al. Fresh and cryopreserved arterial homografts in the treatment of prosthetic graft infections: Experience of the Italian Collaborative Vascular Homograft Group. Ann Vasc Surg 1998;12:457-62.
35. Yeager RA, Taylor LM Jr, Moneta GL, et al. Improved results with conventional management of infrarenal aortic infection. J Vasc Surg 1999;30:76-83.
36. Wunderly D, Maloney J, Edel T, McHenry M, McCarthy PM. Infections in implantable cardioverter defibrillator patients. Pacing Clin Electrophysiol 1990;13:1360-4.
37. Turkisher V, Priel I, Dan M. Successful management of an infected implantable cardioverter defibrillator with oral antibiotics and without removal of the device. Pacing Clin Electrophysiol 1997;20:2268-70.
38. Mela T, McGovern BA, Garan H, et al. Long-term infection rates associated with the pectoral versus abdominal approach to cardioverter-defibrillator implants. Am J Cardiol 2001;88:750-3.
39. Goldstein DJ, Oz MC, Rose EA. Implantable left ventricular assist devices. N Engl J Med 1998;339:1522-33.
40. Sinha P, Chen JM, Flannery M, Scully BE, Oz ME, Edwards NM. Infections during left ventricular assist device support do not affect posttransplant outcomes. Circulation 2000;102: Suppl III:III-194-III-199.
41. Brandt CM, Sistrunk WW, Duffy MC, et al. Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention. Clin Infect Dis 1997;24:914-9.
42. Crockarell JR, Hanssen AD, Osmon DR, Morrey BF. Treatment of infection with debridement and retention of the components following hip arthroplasty. J Bone Joint Surg Am 1998;80:1306-13.
43. Segreti J, Nelson JA, Trenholme GM. Prolonged suppressive antibiotic therapy for infected orthopedic prostheses. Clin Infect Dis 1998;27:711-3.
44. Meehan AM, Osmon DR, Duffy MCT, Hanssen AD, Keating MR, Outcome of penicillin-susceptible streptococcal prosthetic joint infection treated with debridement and retention of the prosthesis. Clin Infect Dis 2003;36:845-9.
45. Grimer RJ, Belthur M, Chandrasekar C, Carter SR, Tillman RM. Two-stage revision for infected endoprostheses used in tumor surgery. Clin Orthop 2002;395:193-203.
46. Whitehead WE, Kestle JRW. The treatment of cerebrospinal fluid shunt infections: results from a practice survey of the American Society of Pediatric Neurosurgeons. Pediatr Neurosurg 2001;35:205-10.
47. Kulkarni AV, Rabin D, Lamberti-Pasculli M, Drake JM. Repeat cerebrospinal fluid shunt infection in children. Pediatr Neurosurg 2001;35:66-71.
48. Schreffler RT, Schreffler AJ, Wittler RR. Treatment of cerebrospinal fluid shunt infections: a decision analysis. Pediatr Infect Dis J 2002;21:632-6.
49. Mulcahy JJ. Surgical management of penile prosthesis complications. Int J Impot Res 2000;12:Suppl 4:S108-S111.